Lundbeck news - the latest biotech news from Labiotech.eu

Home Lundbeck

Latest Posts

denmark biotech industry

Interview 20 Nov 2018

Why Denmark Is a Strong Player in Europe’s Biotech Industry

Denmark is a rapidly growing hotspot for biotech. During the BIO-Europe conference in Copenhagen, I talked to Mette Kirstine Agger, Managing Partner at the life sciences investor Lundbeckfonden Ventures, to…

November 20, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

lundbeck prexton therapeutics acquisition parkinsons

News and Trends 16 Mar 2018

Lundbeck Signs Near €1Bn Acquisition of Swiss Parkinson’s Biotech

Lundbeck is acquiring Prexton Therapeutics in a deal that could reach up to €905M if the Swiss company's Parkinson's treatment proves successful. Danish pharma Lundbeck has decided to boost its…

March 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

confo therapeutics lundbeck gpcr2 1

News and Trends 26 Sep 2017

Belgian Biotech Teams Up With Lundbeck to Collaborate on Drug Discovery

Confo and Lundbeck have joined forces to push through drug discovery against a tough-to-target protein using Confo's special technology. Confo Therapeutics develops small antibody fragments, 'Confobodies', that stabilize G-protein coupled receptors (GPCRs). Although Lundbeck has…

September 26, 2017 - 2 minutesmins - By Alex Dale

Bonesupport IPO biomaterial bone repair

More News! 21 Jun 2017

Swedish IPO raises €51M for Biomaterials to Repair Bone

Bonesupport has gone public in the Swedish stock market to push its pipeline and increase sales of biomaterials to regenerate bone tissue. Bonesupport is a company based in Lund, Sweden, that…

June 21, 2017 - 1 minutemin - By Clara Rodríguez Fernández

ADVERTISEMENT

shutterstock 562105219

News and Trends 30 Jan 2017

‘Trojan Horse’ Shark Antibodies could beat the Blood Brain Barrier

Ossianix, partnered with Lundbeck, is developing shark antibodies that can help therapeutics cross the blood brain barrier. Ossianix develops shark-inspired antibody fragments, VNARs, with outstanding properties thanks to their small…

January 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

biotech investor europe

News and Trends 22 Apr 2022

European Biotech Investors Brace for Volatility in 2022

After gathering huge investment funds in 2021, European biotech investors took a breather in the first quarter of 2022, with the plan to steadily fund private biotechs amid a tumultuous…

April 22, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Aug 2015

Lundbeck dismisses 1,000 employees to stay competitive

Lundbeck's new CEO Kåre Schultz completely restructures the company to regain profitability. About 1/6th of the company's employees will have to leave for that reason. In May, former president and COO of…

August 20, 2015 - 2 minutesmins - By Philip Hemme

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields

Want to advertise with us?

Reach us here!

Got a news story for us?

Send it to us here